$PWP

Perella Weinberg Partners (PWP): Results of Operations and Financial Condition

Perella Weinberg Partners (PWP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026ex991-earningsrelease.htm EX-99.1 Document Exhibit 99.1 Perella Weinberg Reports Second Quarter 2026 Results Financial Overview - Second Quarter • Revenues of $157 Million, Up 1% From a Year Ago • GAAP Pre-Tax Income of $6 Million, Adjusted Pre-Tax Income of $27 M

Original reporting
Published Jul 31, 2026, 11:44 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 11:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PWP
Neutral
medium confidence
Mentioned
$PWP
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PWPNeutralMed
01

Why it matters

Traders can reassess near-term valuation support from capital returns (dividend and net share retirement) against revenue softness in the first half and cost structure changes tied to headcount realignment.

02

Market read

Fresh quarterly financials plus explicit capital return and acquisition timing are actionable for positioning, though the release lacks detailed forward guidance.

03

What to watch

GAAP results include realignment and amortization effects, while adjusted compensation margin changes and litigation insurance recoveries may distort underlying operating momentum.

Relevance 7/10Novelty 7/10Timing: filed pre-market today, Q2 results and dividend disclosed

Background

The filing is an SEC Form 8-K with Exhibit 99.1 reporting Perella Weinberg’s second quarter 2026 results and related financial condition updates.

Company-level read

Ticker impact

$PWPNeutralMedium confidence
Context

Perella Weinberg reported Q2 2026 results, including $157M revenue (+1% YoY) and GAAP diluted EPS of $0.06, plus a $0.07 quarterly dividend.

Expected impact

Likely modest, with traders focusing on revenue trend (down 17% in H1) versus capital return (dividend and $73M returned) and the stated Gleacher Shacklock acquisition timing.

Evidence & confidence

This is a primary earnings-style disclosure with multiple concrete figures (revenues, EPS, cash/no debt, buybacks, dividend) but no explicit forward guidance beyond expecting the Gleacher Shacklock acquisition close in Q3.

Market effects

Signals ongoing demand mix in investment banking advisory (M&A contribution up YoY, financing/capital solutions down) for boutique IB peers.

Primarily US-focused capital markets activity reflected in reported revenue drivers.

Limited, as the disclosure is company-specific and does not cite global macro shocks or cross-border regulatory actions.

Counterpoint

The headline Q2 revenue growth (+1% YoY) may mask a weaker first-half trend (-17% YoY), suggesting the quarter could be less durable than it appears.

Key entities

  • Perella Weinberg Partners

    NASDAQ-listed investment bank reporting Q2 2026 results, capital management actions, and expected acquisition close timing.

  • Gleacher Shacklock

    Announced acquisition target expected to close in the third quarter, per CEO statement in the release.

  • Andrew Bednar

    CEO and Chairman quoted on transaction pace and acquisition timing.

Related articles

$PWPMedAI 8/10

Why Perella Weinberg (PWP) Stock Is Trading Up Today

Perella Weinberg Partners (PWP) shares rose about 17.5% after the firm reported Q2 results. Adjusted EPS was $0.20 versus $0.06 expected and $0.09 a year earlier. Revenue was $156.5 million, flat year over year but 8.1% above expectations, with a 3.9% pre-tax margin. The stock remains below its 52-week high.

$PWPMedAI 8/10

Why is Perella Weinberg Partners stock surging today?

Perella Weinberg Partners (PWP) shares rose 19.3% after the firm reported Q2 results above lowered expectations. Adjusted EPS was $0.20 versus about $0.10 consensus, with revenue at $157 million, up 1% YoY. The article also cites promotions to partner and a $0.07 quarterly dividend, plus supportive sector and Fed backdrop.

$PWPMed

Perella Weinberg (NASDAQ:PWP) Delivers Impressive Q2 CY2026

Financial advisory firm Perella Weinberg Partners (NASDAQ: PWP) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $156.5 million. Its non-GAAP profit of $0.20 per share was significantly above analysts’ consensus estimates. Is now the time to buy Perella Weinberg? Find out by accessing our full research report, it’s free.

$VNTMed

Vontier Corporation Q2 2026 Earnings Call Summary

Vontier’s Q2 2026 earnings call said Environmental & Fueling Solutions demand for dispensers and aftermarket parts drove results, while margin rose on VBS simplification (32 to 8 dispenser platforms, 1,400 SKUs). Full-year EPS guidance was raised, aided by accelerated share repurchases and tariff refunds. The EKOS acquisition targets $15m to $17m revenue by FY2027 and double-digit ROIC by year 3.

Med

Fiserv, Inc. Q2 2026 Earnings Call Summary

Fiserv reported a Q2 2026 earnings call update, revising full-year 2026 organic revenue guidance to minus 1% to flat, citing Argentina macro volatility, slower client implementation timelines, slower execution on growth initiatives, and incremental technology infrastructure investments. Management said recurring revenue is about 85% of adjusted revenue. Fiserv plans >$100M tech spend in H2 2026, divests non-core businesses, and expects double-digit adjusted EPS growth in 2027-2029.